Search

Search Constraints

You searched for: Author/Creator Phillips, Tanyanika

Search Results

2. Innovation in recruitment and curricular design for diversity, equity, and inclusion (DEI) education for hematology-oncology (HO) trainees. Issue 28 (1st October 2022)

3. Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline. Issue 35 (10th December 2021)

4. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. Issue 36 (20th December 2021)

5. Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline. Issue 12 (20th April 2022)

6. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update. Issue 9 (20th March 2021)

7. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2022.2. Issue 5 (10th February 2023)

8. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline. Issue 28 (1st October 2022)

9. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2. Issue 5 (10th February 2023)

10. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline. Issue 28 (1st October 2022)